Verapamil for Neuroprotection in Stroke

Clinical trial NCT03347786 · RECRUITING

Trial details

NCT number: NCT03347786
Sponsor: Global Neurosciences Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2017-04-20
Primary completion: 2026-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.